Delivery Order SPE2DB22D1052-SPE2DB25FU7VM
Award Date
10/21/24
Potential Completion Date
10/22/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,242.91, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of February 25, 2025 and is a Firm Fixed Price contract. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,552.01, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a period of performance through April 1, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" and has a ceiling value of $6,918.11. The contract is a firm fixed-price, non-set-aside contract with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a $1,719.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XULANE 150-35 MCG/DAY PATCH 3S. The contract has an ultimate completion date of June 24, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a ceiling value of $4,213.85 and a period of performance through March 11, 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,137.07 firm-fixed-price contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a performance period through May 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,015.05 firm fixed-price contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription medication, with a completion date of September 12, 2024. The contract is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,202.78, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of April...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,965.60 firm fixed-price contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a period of performance extending through June 18, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,861.64, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 2, 2025. The contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp...